These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10561677)

  • 1. Effects of low-dose monophasic levonorgestrel with ethinyl estradiol preparation on serum lipid levels: A twenty-four month clinical trial.
    Young RL; DelConte A
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):59-62. PubMed ID: 10561677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of a low-dose monophasic preparation of levonorgestrel and ethinyl estradiol on coagulation and other hemostatic factors.
    Archer DF; Mammen EF; Grubb GS
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):63-6. PubMed ID: 10561678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects on ovarian activity of a monophasic oral contraceptive with 100 microg levonorgestrel and 20 microg ethinyl estradiol.
    Coney P; DelConte A
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):53-8. PubMed ID: 10561676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol.
    Reisman H; Martin D; Gast MJ
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):45-52. PubMed ID: 10561675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG).
    Archer DF; Maheux R; DelConte A; O'Brien FB
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):39-44. PubMed ID: 10561674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
    Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H
    Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
    März W; Gross W; Gahn G; Romberg G; Taubert HD; Kuhl H
    Am J Obstet Gynecol; 1985 Oct; 153(3):287-93. PubMed ID: 2931988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alesse: leading the shift to 20 microg.
    Archer DF
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):37-8. PubMed ID: 10561673
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using a low-dose contraceptive in women 35 years of age and over: 20 microg estradiol/100 microg levonorgestrel.
    Carr BR; DelConte A
    Contraception; 2002 Jun; 65(6):397-402. PubMed ID: 12127636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipoproteins and fatty acid composition after "minipill".
    Sassolas A; Lagarde M; Guichardant M; Quincy C; Dechavanne M
    Contraception; 1983 Oct; 28(4):357-68. PubMed ID: 6421540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
    Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
    Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyl estradiol on lipid metabolism in comparison with two levonorgestrel preparations.
    Kloosterboer HJ; Rekers H
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):370-3. PubMed ID: 2142577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 microg or 30 microg) and levonorgestrel (100 microg or 150 microg) on lipoprotein metabolism.
    Scharnagl H; Petersen G; Nauck M; Teichmann AT; Wieland H; März W
    Contraception; 2004 Feb; 69(2):105-13. PubMed ID: 14759614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
    Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel.
    Larsson-Cohn U; Wallentin L; Zador G
    Horm Metab Res; 1979 Jul; 11(7):437-40. PubMed ID: 225252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hirsutism with ethinyl estradiol-desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity.
    Escobar-Morreale HF; Lasunción MA; Sancho J
    Fertil Steril; 2000 Oct; 74(4):816-9. PubMed ID: 11020530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. II. Serum lipoproteins and apolipoproteins.
    Ahrén T; Lithell H; Victor A; Vessby B; Johansson ED
    Contraception; 1981 Oct; 24(4):451-68. PubMed ID: 6797786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.